Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
about
Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis.A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formationFrom basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research"A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology.A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets.Forget about thrombosis: Platelets and Alzheimer's disease, yet another sticky situation.Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.Targeted antithrombotic protein micelles.Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation.A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.Destination Known: Targeted Drug Delivery in Atherosclerosis and ThrombosisPlatelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis
P2860
Q27300813-B1DC6738-CBC5-4177-BEB5-2FFC81C8C389Q27331904-9BCDCC29-00CC-4B3B-B7AB-4AF8CF44367BQ28073354-B903FF8D-11E0-45FA-B36F-D36BF0DC4C0AQ33588134-70F1CDA3-AEB7-4CD8-B7ED-92CFC1F5ECF5Q36261019-28A3E209-15B9-4DD8-98E2-3FEF6D268188Q37464638-AB991F5D-67A9-41B8-93C4-03A2FB316DD9Q38843564-8A34CFEE-662D-41C2-BC0D-D3F150FF8EEDQ41430279-31C13C4A-8657-42CD-BE01-195C38E675EEQ41628315-5A7BA288-E24C-4DFA-9280-8255588657ABQ41694800-82D4F46A-4773-4C55-B70E-35618BFF4650Q42617570-E283F50E-AE09-40CF-9957-BB6E7311B190Q50974811-E84218F3-2677-4262-8610-53655B7EB771Q51020147-A34D2279-43F8-40D7-A9A0-2C3DBCE37D5DQ52662484-FEDD5776-580A-4D11-AD16-DE2E831560B0Q57342839-8EC31BD7-7D48-4E01-89A7-ABA0918F9BA2Q58792339-D28B6C25-ECBA-4FBA-9125-D1B1355926F3
P2860
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@ast
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@en
type
label
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@ast
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@en
prefLabel
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@ast
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@en
P2093
P2860
P50
P1433
P1476
Delayed targeting of CD39 to a ...... rombotic potency and bleeding?
@en
P2093
Andreas Straub
Carly Selan
Carolyn A Haller
Elliot L Chaikof
Jan David Hohmann
Stefanie Krajewski
P2860
P304
P356
10.1182/BLOOD-2012-08-449694
P407
P577
2013-02-04T00:00:00Z